rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of european ancestry
To the Editor:
Recently, rare loss-of-function genetic variants in the SIAE gene, which encodes sialic acid acetylesterase, were reported to predispose to multiple autoimmune diseases 1 . In a pooled analysis of samples from ten autoimmune diseases, Surolia et al. identified 12 distinct nonsynonymous SIAE risk variant genotypes present in 24 of 923 affected persons (2.60%) versus 2 of 648 controls (0.31%; P = 0.0002; odds ratio of 8.6 ) that the authors considered to be "functionally defective SIAE alleles" because they result in defects in either esterase activity or secretion 1 . These nonsynonymous markers comprised one common allele frequency variant (rs78778622; encoding a p.Met89Val substitution in SIAE) and 11 rare allele frequency variants. Homozygosity for the SIAE variant (rs78778622, GG) causing the p.Met89Val alteration that resulted in a secretion-defective mutant was reported in 8 of 923 affected individuals (0.87%) but in none of the 648 control subjects 1 . To date, in contrast to the numerous genome-wide association studies for common variants, there have been only a few studies reporting rare variants of large effect predisposing individuals to clinically typical autoimmune disease phenotypes, despite much recent enthusiasm for exome sequencing in these genetically complex conditions.
We sought to replicate and extend these SIAE findings in a much larger, independent study of autoimmune and chronic immune diseases (atopic eczema, celiac disease, Crohn's disease, Graves' disease, Hashimoto's disease, juvenile idiopathic arthritis, multiple sclerosis, rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus, type 1 diabetes and ulcerative colitis). Individuals included in the study were of European origin from five geographic regions. Common genetic risk variants (minor allele frequency >5%) show substantial overlap in multiple autoimmune and immune-mediated disorders 2 ; therefore, we considered that the analysis pooled across autoimmune diseases performed by Surolia et al. was rational and performed the same analysis on our data.
In 66,924 subjects, we found the frequencies of homozygotes for the SIAE variant encoding the p.Met89Val alteration to be similar between affected individuals (12 autoimmune diseases, comprising 99.6% of the cases in the original report 1 ) and controls (Table 1) , with 60 UK control subjects (0.32%) being homozygous for the variant. We found homozygotes for this SIAE variant in all control collections, occurring at similar genotype frequencies as in cases. To confidently exclude any bias due to population stratification or admixture, we genotyped the variant encoding SIAE p.Met89Val in 4,805 independent affected offspring-parent trios of European origin (five autoimmune diseases; Table 2 ). We found no evidence indicating an effect of the p.Met89Val alteration on autoimmune disease risk.
We then studied eight additional rare SIAE variants in 43,378 subjects (10 diseases and controls). These eight variants, along with homozygotes for the variant encoding SIAE p.Met89Val, were the ones reported by Surolia et al. 1 Table 2 ) nor any evidence for misinheritance that would suggest de novo mutations.
Our data, therefore, do not support the genetic association findings of Surolia et al. 1 . We note that a linkage signal would be predicted for variants of the large effect size reported 1,3 , yet none was observed at SIAE in type 1 diabetes in a large recent study 4 . We have no reason to doubt the reported effect of the variants on SIAE function 1 . However, even when nonsynonymous variants in a gene appear and are experimentally proven to be functionally relevant, the prior probability that such variants affect disease susceptibility may not be altered, as the coding exome contains many thousands of functional rare variants that do not influence phenotype 5, 6 . Fine-scale population substructure may confound rare variant association studies, may be difficult to detect with current principal-component methods developed using common SNPs and may only be definitively excluded by family-based association analysis.
Investigators performing genome-wide association studies of common variants have developed guidelines for reporting new associations, including both stringent statistical thresholds (necessitating large sample sizes) and independent replication data sets. Similar approaches, ideally including family-based association analysis, should be applied to the study of rare variants, as we previously described in the analysis of the IFIH1 gene in type 1 diabetes 7 c o r r e s p o n d e n c e Meta-analysis P = 0.124
